15.99
price down icon0.06%   -0.010
after-market Dopo l'orario di chiusura: 15.89 -0.10 -0.63%
loading

Onkure Therapeutics Inc Borsa (OKUR) Ultime notizie

pulisher
Nov 20, 2024

OnKure Therapeutics Faces Post-Merger Hurdles: Integration Challenges and Talent Competition Threaten Growth - MSN

Nov 20, 2024
pulisher
Nov 14, 2024

OnKure Therapeutics (OKUR) vs. The Competition Head-To-Head Analysis - Defense World

Nov 14, 2024
pulisher
Nov 09, 2024

OnKure Therapeutics' (OKUR) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 09, 2024
pulisher
Nov 07, 2024

OnKure Therapeutics announces accounting firm change - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Form 424B3 OnKure Therapeutics, - StreetInsider.com

Nov 07, 2024
pulisher
Nov 07, 2024

Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 05, 2024

OnKure to Present at the Stifel 2024 Healthcare Conference - GlobeNewswire

Nov 05, 2024
pulisher
Nov 01, 2024

OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium - GlobeNewswire

Nov 01, 2024
pulisher
Oct 25, 2024

VTv, OnKure Terminate Cellular Drug Licensing Agreement - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

vTv Therapeutics ends key license agreement with OnKure - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

vTv Therapeutics ends key license agreement with OnKure By Investing.com - Investing.com UK

Oct 25, 2024
pulisher
Oct 25, 2024

vTv Therapeutics Faces License Agreement Termination - TipRanks

Oct 25, 2024
pulisher
Oct 24, 2024

OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond (OKUR) - Seeking Alpha

Oct 24, 2024
pulisher
Oct 21, 2024

Q3 Earnings Forecast for OKUR Issued By HC Wainwright - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Analysts Offer Predictions for OKUR Q1 Earnings - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

What is HC Wainwright's Estimate for OKUR Q1 Earnings? - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

HC Wainwright Reiterates Buy Rating for OnKure Therapeutics (NASDAQ:OKUR) - MarketBeat

Oct 17, 2024
pulisher
Oct 14, 2024

OnKure Therapeutics (OKUR) Stock Rebounds In Extended Session - Stocks Telegraph

Oct 14, 2024
pulisher
Oct 11, 2024

OnKure started at outperform by Oppenheimer, OKI-219 potential cited - MSN

Oct 11, 2024
pulisher
Oct 11, 2024

OnKure shares initiated with Outperform rating on drug potential - Investing.com India

Oct 11, 2024
pulisher
Oct 10, 2024

Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm - Benzinga

Oct 10, 2024
pulisher
Oct 10, 2024

OnKure shares initiated with Outperform rating on drug potential By Investing.com - Investing.com Canada

Oct 10, 2024
pulisher
Oct 10, 2024

This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 10, 2024
pulisher
Oct 08, 2024

Reneo Pharmaceuticals Completes Merger and Name Change to OnKure Therapeutics, Inc. - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Newley merged OnKure raises $65 million - The Pharma Letter

Oct 08, 2024
pulisher
Oct 07, 2024

Boulder’s OnKure goes public with merger; key drug trial underway - Boulder Daily Camera

Oct 07, 2024
pulisher
Oct 07, 2024

OnKure and Reneo Pharmaceuticals complete merger - Pharmaceutical Technology

Oct 07, 2024
pulisher
Oct 07, 2024

Galapagos investor gets board seat; OnKure completes merger with Reneo - Endpoints News

Oct 07, 2024
pulisher
Oct 05, 2024

Reneo Pharmaceuticals stockholders approval merger with OnKure - TipRanks

Oct 05, 2024
pulisher
Oct 04, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million - StockTitan

Oct 04, 2024
pulisher
Oct 04, 2024

Reneo stockholders approve merger with OnKure - MSN

Oct 04, 2024
pulisher
Oct 02, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - GlobeNewswire

Oct 02, 2024
pulisher
Sep 22, 2024

This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy? - AOL

Sep 22, 2024
pulisher
Sep 17, 2024

Here's Why Everyone's Talking About Summit Therapeutics - AOL

Sep 17, 2024
pulisher
Sep 10, 2024

Oppenheimer sees competition risk as Relay Therapeutics stock stumbles on trial results - Investing.com

Sep 10, 2024
pulisher
Aug 13, 2024

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results - Yahoo Finance

Aug 13, 2024
pulisher
Jul 26, 2024

OnKure hires ex-Pfizer research leader as chief scientific officer - BizWest

Jul 26, 2024
pulisher
Jun 24, 2024

OnKure Therapeutics - The Pharma Letter

Jun 24, 2024
pulisher
Jun 24, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc.RPHM - PR Newswire

Jun 24, 2024
pulisher
Jun 19, 2024

OnKure Announces the Appointment of Rogan Nunn, J.D., as General Counsel and Secretary - GlobeNewswire

Jun 19, 2024
pulisher
May 28, 2024

Reneo Set to Close After Test Failure - Orange County Business Journal

May 28, 2024
pulisher
May 17, 2024

Public Equity Report: Erasca reboots, Telix plans NASDAQ listing - BioCentury

May 17, 2024
pulisher
May 15, 2024

Wilson Sonsini Advises Reneo Pharmaceuticals on IP Matters Related to OnKure Merger - Wilson Sonsini

May 15, 2024
pulisher
May 14, 2024

Reneo Pharma to merge with OnKure - The Pharma Letter

May 14, 2024
pulisher
May 13, 2024

With first drug trial underway, OnKure inks merger with Reneo Pharma to go public - BizWest

May 13, 2024
pulisher
Apr 16, 2024

Seven biotech companies climbing their way up in Colorado - Labiotech.eu

Apr 16, 2024
pulisher
Jan 08, 2024

HDAC Inhibitor Clinical Trial Pipeline Appears Robust With - GlobeNewswire

Jan 08, 2024
pulisher
Dec 20, 2023

Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech

Dec 20, 2023
pulisher
May 26, 2023

The Week’s 10 Biggest Funding Rounds: Anthropic Generates Another Huge Round, Biotech Has Big Week - Crunchbase News

May 26, 2023
pulisher
May 23, 2023

OnKure Therapeutics Announces $54 Million Series C Financing - GlobeNewswire

May 23, 2023
pulisher
Feb 28, 2023

2023 Destination Startup® drives investment in intermountain west university innovations - University of Colorado Boulder

Feb 28, 2023
pulisher
Feb 09, 2022

Biogen’s Friedl-Naderer joins Vir as CBO - BioCentury

Feb 09, 2022
pulisher
Dec 14, 2021

OnKure Therapeutics Announces Positive Topline First-in-Human Phase 1 Results for OKI-179 - Business Wire

Dec 14, 2021
pulisher
Oct 14, 2021

OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial - Fierce Biotech

Oct 14, 2021
pulisher
May 19, 2021

RPHMReneo Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

May 19, 2021
pulisher
Mar 04, 2021

OnKure, Inc. Raises $55 Million Series B Financing - Business Wire

Mar 04, 2021
pulisher
Nov 07, 2019

Tyler D. Baguley - Wilson Sonsini

Nov 07, 2019
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):